BIO Asia-Tokyo

Mar 10-11, 2020・Tokyo, Japan

Program Overview

Event programming will focus on major new regulatory changes in cross-border investing with United States companies (CFIUS reform), reimbursement reform in Japan, and cross-Asia investment trends, among other topics. There will be government and policy experts from Japan and the U.S. speaking on new initiatives to support international market expansion and accelerate technology transfer from university research discoveries into commercialization.

EVT-ASIA20.jpg
Speakers

Meet this year's roster of industry leaders who will be speaking at the event.

EVT-ASIA20.jpg
Program Topics

Get the pulse on on deal-making and investment patterns trends in the Japanese market.

EVT-ASIA20
Schedule of Events

View a day-by-day schedule of events.

EVT-ASIA20.jpg
See Who Presented in 2019

Company presentations are an integral programming element at the BIO Asia International Conference that allow companies to discuss their pipeline, R&D activities, and future goals to this exclusive audience. 

EVT-ASIA20.jpg
Apply to Present in 2020

Company presenters tend to receive double the number of requests than non-presenters, and schedule twice as many meetings than non-presenting companies. 

Statement on Diversity

BIO is committed to workforce development, diversity, and inclusion, and incorporates these values into all aspects of BIO operations. Program development for BIO’s events will be considered in this light, with specific attention paid to speakers’ gender, race, ethnic background, sexual orientation, and gender identity, as well as their company’s focus, financing, geographic location, and size.  Diverse programming at BIO’s events allows BIO to remain a strong leader in efforts to ensure that the biotechnology industry can attract, develop, and retain a high-quality, globally competitive employee talent pool. Learn more about Workforce Development, Diversity, & Inclusion at BIO.